Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-11-03

FDA Approved: AMMONIA N 13 — Original Application (University of Alabama at Birmingham)

View source ↗

Summary

FDA approved the original application for Ammonia N-13 (NH3N13), a radiopharmaceutical imaging agent developed by the University of Alabama at Birmingham for PE…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AMMONIA N 13 (NH3N13)

Snippet

ORIG AP for AMMONIA N 13 (NH3N13)